Thomas L. Miller, PhD

Executive Vice President Clinical Development
Enalare Therapeutics Inc
Woodstown, New Jersey

PhD and academic body of work in Pulmonary Physiology and lung structure function. Twenty years in industry developing transnational therapies.

Presentation(s):

• P-098 - (Poster #98) Bedside Suite of Aggregated Technologies to Monitor and Characterize Post-operative Respiratory Depression in the Clinical and Research Milieu – The Data Acquisition Module (DAM)

  Thursday, September 4, 2025
  4:00 PM - 5:30 PM PST

• P-028 - (Poster #28) e-Delphi Consensus Study for Defining, Evaluating, and Managing Postoperative Respiratory Depression (PORD)

  Thursday, September 4, 2025
  4:00 PM - 5:30 PM PST

• P-052 - (Poster #52) Observations from a Rat Model of Fentanyl-Induced Changes Respiratory Function

  Thursday, September 4, 2025
  4:00 PM - 5:30 PM PST

• P-066 - (Poster #66) Summary of Traditional and an Innovative Approach for Mitigation of Postoperative Respiratory Depression

  Thursday, September 4, 2025
  4:00 PM - 5:30 PM PST